Home > Newsletters > FDAnews Device Daily Bulletin > FDA Warns Epimed International for Supplier Control, Procedural Issues
FDAnews Device Daily Bulletin
Oct. 15, 2012 | Vol. 9 No. 202
FDA Warns Epimed International for Supplier Control, Procedural Issues
Lax process and quality control of supplied components helped land Irving, Texas-based Epimed International an FDA warning letter. Following a May 1 to 17 inspection of the company’s Johnstown, N.Y., plant, the FDA recounted flaws in the company’s supplier quality process, including a failure to establish and maintain procedures for accepting incoming products.
Devices & Diagnostics Letter
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.